Association between HIV infection and hypertension: a global systematic review and meta-analysis of cross-sectional studies

Abstract

Background Improved access to effective antiretroviral therapy has meant that people living with HIV (PLHIV) are surviving to older ages. However, PLHIV may be ageing differently to HIV-negative individuals, with dissimilar burdens of non-communicable diseases, such as hypertension. While some observational studies have reported a higher risk of prevalent hypertension among PLHIV compared to HIV-negative individuals, others have found a reduced burden. To clarify the relationship between HIV and hypertension, we identified observational studies and pooled their results to assess whether there is a difference in hypertension risk by HIV status. Methods We performed a global systematic review and meta-analysis of published cross-sectional studies that examined hypertension risk by HIV status among adults aged > 15 (PROSPERO: CRD42019151359). We searched MEDLINE, EMBASE, Global Health and Cochrane CENTRAL to August 23, 2020, and checked reference lists of included articles. Our main outcome was the risk ratio for prevalent hypertension in PLHIV compared to HIV-negative individuals. Summary estimates were pooled with a random effects model and meta-regression explored whether any difference was associated with study-level factors. Results Of 21,527 identified studies, 59 were eligible (11,101,581 participants). Crude global hypertension risk was lower among PLHIV than HIV-negative individuals (risk ratio 0.90, 95% CI 0.85–0.96), although heterogeneity between studies was high (I2 = 97%, p < 0.0001). The relationship varied by continent, with risk higher among PLHIV in North America (1.12, 1.02–1.23) and lower among PLHIV in Africa (0.75, 0.68–0.83) and Asia (0.77, 0.63–0.95). Meta-regression revealed strong evidence of a difference in risk ratios when comparing North American and European studies to African ones (North America 1.45, 1.21–1.74; Europe 1.20, 1.03–1.40). Conclusions Our findings suggest that the relationship between HIV status and prevalent hypertension differs by region. The results highlight the need to tailor hypertension prevention and care to local contexts and underscore the importance of rapidly optimising integration of services for HIV and hypertension in the worst affected regions. The role of different risk factors for hypertension in driving context-specific trends remains unclear, so development of further cohorts of PLHIV and HIV-negative controls focused on this would also be valuable.

Hypertension and Socioeconomic Status in South Central Uganda: A Population-Based Cohort Study

“…The relationship between hypertension and non-nicotine tobacco products is still unclear. Further analysis pertaining to the inverse relationship between hypertension and smoking as well as HIV positive serostatus will be addressed in future studies [20].…”

HIV, tuberculosis, diabetes mellitus and hypertension admissions and premature mortality among adults in Uganda from 2011 to 2019: is the tide turning?

“…This threatens progress towards eliminating HIV-related deaths, and is supported by findings from Kiragga et al that showed increasing role of NCDs as causes of death among PLHIV on ART in an urban outpatient clinic [ 6 ]. Kwarisiima et al therefore recommend HTN and DM care integration in HIV chronic care clinics to prevent morbidity and mortality from HTN, DM and HIV, tailored to context [ 45 , 46 ].…”

Cardiovascular risk factors and markers of myocardial injury and inflammation in people living with HIV in Nairobi, Kenya: a pilot cross-sectional study

“…These differences probably account for regional discordance in the association between HIV status and prevalence of cardiovascular risk factors that has been observed in the published literature. Positive associations in North America/Europe either become null or even reverse in sub-Saharan Africa 22–26 30–33…”